Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial

Riedl, Marc A., Li, Philip Hei, Adatia, Adil, Cancian, Mauro, Stobiecki, Marcin, Valerieva, Anna D., Grumach, Anete S., Lumry, William Raymond, Soteres, Daniel F., Brodszki, Nicholas, Fili, Natalia Lorena, Hakl, Roman, Kang, Hye-ryun, Karakaya, Gül, Kränke, Birger, Li, H. Henry, Peter, Jonathan Grant, Recke, Andreas L., Tachdjian, Raffi, Triggianese, Paola, Zanichelli, Andrea, Anderson, John T., Aygören-Pürsün, Emel, Craig, Timothy J., Farkas, Henriette, Magerl, Markus, et al., :unav

Open source

DOI: 10.24406/publica-11117
Published: 2026
Container: Not recorded
Publisher: Fraunhofer-Gesellschaft
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.24406/publica-11117,
  title = {Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial},
  author = {Riedl, Marc A. and Li, Philip Hei and Adatia, Adil and Cancian, Mauro and Stobiecki, Marcin and Valerieva, Anna D. and Grumach, Anete S. and Lumry, William Raymond and Soteres, Daniel F. and Brodszki, Nicholas and Fili, Natalia Lorena and Hakl, Roman and Kang, Hye-ryun and Karakaya, Gül and Kränke, Birger and Li, H. Henry and Peter, Jonathan Grant and Recke, Andreas L. and Tachdjian, Raffi and Triggianese, Paola and Zanichelli, Andrea and Anderson, John T. and Aygören-Pürsün, Emel and Craig, Timothy J. and Farkas, Henriette and Magerl, Markus and et al. and :unav},
  year = {2026},
  doi = {10.24406/publica-11117},
  url = {https://doi.org/10.24406/publica-11117}
}

RIS

TY  - JOUR
TI  - Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial
AU  - Riedl, Marc A.
AU  - Li, Philip Hei
AU  - Adatia, Adil
AU  - Cancian, Mauro
AU  - Stobiecki, Marcin
AU  - Valerieva, Anna D.
AU  - Grumach, Anete S.
AU  - Lumry, William Raymond
AU  - Soteres, Daniel F.
AU  - Brodszki, Nicholas
AU  - Fili, Natalia Lorena
AU  - Hakl, Roman
AU  - Kang, Hye-ryun
AU  - Karakaya, Gül
AU  - Kränke, Birger
AU  - Li, H. Henry
AU  - Peter, Jonathan Grant
AU  - Recke, Andreas L.
AU  - Tachdjian, Raffi
AU  - Triggianese, Paola
AU  - Zanichelli, Andrea
AU  - Anderson, John T.
AU  - Aygören-Pürsün, Emel
AU  - Craig, Timothy J.
AU  - Farkas, Henriette
AU  - Magerl, Markus
AU  - et al.
AU  - :unav
PY  - 2026
DO  - 10.24406/publica-11117
UR  - https://doi.org/10.24406/publica-11117
ER  -

APA

A., R. M., Hei, L. P., Adil, A., Mauro, C., Marcin, S., D., V. A., S., G. A., Raymond, L. W., F., S. D., Nicholas, B., Lorena, F. N., Roman, H., Hye-ryun, K., Gül, K., Birger, K., Henry, L. H., Grant, P. J., L., R. A., Raffi, T., Paola, T., Andrea, Z., T., A. J., Emel, A., J., C. T., Henriette, F., Markus, M., al., E., & :unav (2026). Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial. https://doi.org/10.24406/publica-11117

Source records

datacite · retrieved 2026-11-10T10:48:06.386Z